Abstract:Background and Aim: Atypical coronary artery disease (ACAD) is characterized by atypical angina pectoris or silent myocardial ischemia. However, conventional diagnostic techniques are insufficient to identify this subtype of coronary atherosclerotic pathology, and specific and sensitive markers for diagnosing ACAD are still currently lacking. The aim of the present study is to identify a novel serum microRNA (miRNA) expression profile of ACAD patients and evaluate its clinical diagnostic value.Patients and Methods: 127 patients who were diagnosed with ACAD and 54 age-matched controls were enrolled in this study. An initial screen of miRNA expression was performed in serum samples from 35 patients and 20 controls using TaqMan Low Density Array. A stem-loop quantitative reverse-transcription PCR (RT-qPCR) assay was conducted in the training and validation sets to confirm the levels of the altered miRNAs in 122 patients with ACAD and 68 controls. In addition, the potential target genes of the altered miRNAs were predicted using bioinformatics methods.Results: The TaqMan low density array and RT-qPCR analysis identified four serum miRNAs including miR-487a, miR-502, miR-208 and miR-215 that were significantly increased, while one miRNA, miR-29b, that was significantly decreased in ACAD patients compared with normal controls (P < 0.05). The area under the receiver-operating-characteristic (ROC) curve (AUC) for the combined 5 serum miRNAs were 0.850 (95% CI, 0.734-0.966, P < 0.001) and 0.909 (95% CI, 0.858-0.960, P < 0.001) for the training set and validation set, respectively. In addition, target gene prediction showed that these five altered miRNAs are involved in affecting various aspects of cardiac or vascular remodeling, especially in the pathway involving inflammation and fibrosis.Conclusion: Our findings indicate that the five altered serum miRNAs could be novel non-invasive biomarkers for ACAD and may also represent potential therapeutic targets for atherosclerosis and myocardial ischemia.

LncRNA-MIAT Increased in Patients with Coronary Atherosclerotic Heart Disease

Multiple Non-coding ANRIL Transcripts Are Associated with Risk of Coronary Artery Disease: a Promising Circulating Biomarker

Abnormal Expression of Long Non-Coding RNAs in Myocardial Infarction.

Integrative Analysis of Key Microrna-Mrna Complexes and Pathways in Aortic Aneurysm

High Expression of Long Non-Coding RNA MALAT1 Correlates with Raised Acute Respiratory Distress Syndrome Risk, Disease Severity, and Increased Mortality in Sepstic Patients.

The role of long non-coding RNA MIAT in cancers

Increased Plasma Levels of Lncrna H19 and LIPCAR Are Associated with Increased Risk of Coronary Artery Disease in a Chinese Population

Upregulation of the Long Non-coding RNA LINC01480 Is Associated With Immune Infiltration in Coronary Artery Disease Based on an Immune-Related lncRNA-mRNA Co-expression Network

Peripheral Blood Leukocyte Expression of lncRNA MIAT and Its Diagnostic and Prognostic Value in Ischemic Stroke.

MicroRNAs or Long Noncoding RNAs in Diagnosis and Prognosis of Coronary Artery Disease

LncRNA Myocardial Infarction-Associated Transcript (MIAT)/miR-505-5p Axis Regulates Proliferation and Migration of Vascular Smooth Muscle Cells of Hypertension Mice

Correlation between circulating long non-coding RNA growth arrest-specific transcript 5 and coronary artery calcification

Potential roles of microRNAs and long noncoding RNAs as diagnostic, prognostic and therapeutic biomarkers in coronary artery disease

Diagnostic and prognostic significance of serum lncRNA MBNL1-AS1 expression in patients with atherosclerosis

Circulating miR-183-5p levels are positively associated with the presence and severity of coronary artery disease

LncRNA UCA1, miR‐26a, and miR‐195 in coronary heart disease patients: Correlation with stenosis degree, cholesterol levels, inflammatory cytokines, and cell adhesion molecules

Association Between Lecithin: Cholesterol Acyltransferase Activity and Coronary Artery Disease

Altered Serum Micrornas As Novel Diagnostic Biomarkers For Atypical Coronary Artery Disease

The Analysis of Microrna Expression Profiling for Coronary Artery Disease

Reciprocal Changes of Circulating Long Non-Coding RNAs ZFAS1 and CDR1AS Predict Acute Myocardial Infarction

Integrated analysis of differentially m6A modified and expressed lncRNAs for biomarker identification in coronary artery disease